Cost Plus Drugs AI Market Strategy Report - Online Pharmacies

Answer Capsule

Cost Plus Drugs holds the strongest recommendation quality in the online pharmacy category, achieving the highest net sentiment score at 0.68 and a valid recommendation coverage of 15.8%. The brand leads in pricing and cost evaluation prompts, where its transparent pricing model is frequently cited as a competitive advantage. Its clearest weakness is a lower raw mention presence rate compared to Amazon Pharmacy and GoodRx, which limits total captured recommendation value despite strong per-mention performance. The clearest opportunity is closing the gap with Amazon Pharmacy in comparison and evaluation prompts, where Cost Plus Drugs currently captures less than half the recommendation value of the category leader.

Who This Report Is For

This report is for executives, marketing leaders, and digital strategy teams at Cost Plus Drugs who need to understand how AI platforms are recommending the brand versus competitors in the online pharmacy category.

Report Card

• Report type: AI Company Market Strategy Report
• Target company: Cost Plus Drugs
• Category / market studied: Online Pharmacies
• Reporting month: June 2026
• AI platforms tracked: ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity
• Public high-intent clusters: 3 (Best Online Pharmacy Discovery and Evaluation, Online Pharmacy Comparison and Alternatives, Online Pharmacy Pricing and Cost Evaluation)
• AI observations analyzed: 1,431
• Competitors tracked: Amazon Pharmacy, Capsule, CVS Pharmacy, Express Scripts, GoodRx, Honeybee Health, Optum Rx, PillPack, Walgreens

Executive Summary

Cost Plus Drugs occupies a strong but incomplete position in AI-generated pharmacy recommendations. Across 1,431 observations spanning six major AI platforms, the brand appears in 365 responses and earns 226 valid recommendations, giving it a 15.8% valid recommendation coverage rate. This is the second-highest coverage in the category behind Amazon Pharmacy at 23.6%.

The brand's net sentiment score of 0.68 is the highest in the category, driven by 251 positive mentions against 112 neutral and 2 negative mentions. When AI systems reference Cost Plus Drugs, they do so in a positive or recommending context in the overwhelming majority of cases rather than a neutral or cautionary one. The average recommended rank of 2.16 places Cost Plus Drugs consistently in the top tier of AI-generated shortlists.

The strongest cluster for Cost Plus Drugs is Best Online Pharmacy Discovery and Evaluation, where it captures $5.15 million in monthly AI authority value, narrowly leading Amazon Pharmacy at $4.71 million. The weakest cluster is Online Pharmacy Comparison and Alternatives, where Cost Plus Drugs captures only $829,000 compared to Amazon Pharmacy's $2.35 million, indicating a significant gap at the evaluation stage.

The strongest platform signal is on Google AI Mode, where Cost Plus Drugs captures $2.4 million in monthly AI authority value with a 12.9% valid recommendation coverage. The clearest platform gap is on Perplexity, where the brand achieves only a 0.5% valid recommendation coverage rate, suggesting its public evidence layer is not well represented on that platform.

Cost Plus Drugs is the strongest challenger in this category by sentiment and recommendation quality. The path to category leadership runs through closing the comparison-stage prompt gap and expanding the citation sources that support evaluation-stage responses across all six platforms.

What Cost Plus Drugs Is Winning

Highest net sentiment in the category. Cost Plus Drugs achieves a net sentiment score of 0.68, the highest among all 10 tracked companies. AI systems frame the brand positively in the vast majority of references, a meaningful structural advantage in a trust-sensitive category like online pharmacies.

Pricing authority. In the Online Pharmacy Pricing and Cost Evaluation cluster, Cost Plus Drugs leads narrowly with $1.35 million in captured AI authority value versus Amazon Pharmacy at $1.34 million. The brand's transparent pricing model is frequently cited as a competitive advantage in cost-related prompts.

Strong recommendation conversion. With a valid recommendation coverage of 15.8%, Cost Plus Drugs converts mentions into recommendations at a rate nearly three times higher than Walgreens and CVS Pharmacy. The 12.2% top-three rate and 5.6% rank-one rate place it consistently near the front of AI shortlists.

ChatGPT and Google AI Mode performance. On ChatGPT, Cost Plus Drugs achieves a 26.4% valid recommendation coverage rate, the highest of any platform for the brand. On Google AI Mode, it captures $2.4 million in monthly AI authority value, its strongest platform by total value.

Where Cost Plus Drugs Has the Clearest AI Visibility Gaps

Comparison and evaluation prompts. In the Online Pharmacy Comparison and Alternatives cluster, Cost Plus Drugs captures only $829,000 in monthly AI authority value compared to Amazon Pharmacy's $2.35 million. This is a 2.8x gap in a cluster with a 1.25 buyer stage multiplier, meaning higher purchase intent than discovery prompts. The brand appears in 111 of 478 observations in this cluster but earns only 66 valid recommendations, suggesting it is frequently listed but not consistently chosen as the top option.

Perplexity platform weakness. On Perplexity, Cost Plus Drugs achieves only a 0.5% valid recommendation coverage rate, with just 1 valid recommendation out of 201 observations. Amazon Pharmacy achieves a 3.5% coverage rate on Perplexity, and GoodRx achieves 9.5%. The gap suggests Cost Plus Drugs lacks the citation sources or public evidence layer that Perplexity prioritizes in pharmacy-related queries.

Raw mention presence gap. Cost Plus Drugs appears in 25.5% of all observations, compared to Amazon Pharmacy at 48.8% and GoodRx at 40.3%. The brand's recommendation conversion is strong, but its lower mention rate limits total captured recommendation value. Expanding the public evidence layer could increase the frequency with which AI systems retrieve and cite the brand across platforms.

Copilot recommendation gap. On Copilot, Cost Plus Drugs achieves a 19.8% valid recommendation coverage rate. Amazon Pharmacy achieves 20.7% and GoodRx achieves 29.3% on the same platform. GoodRx's dominance on Copilot suggests that platform may favor coupon-based comparison models over direct pharmacy services, a pattern worth monitoring as Cost Plus Drugs develops its comparison-stage content.

Biggest Opportunity

The clearest opportunity for Cost Plus Drugs is closing the recommendation gap in the Online Pharmacy Comparison and Alternatives cluster. This cluster carries a 1.25 buyer stage multiplier, reflecting higher purchase intent than discovery prompts, and Cost Plus Drugs currently captures $829,000 in AI authority value here versus Amazon Pharmacy's $2.35 million. The gap is not driven by absence: Cost Plus Drugs appears in 111 of 478 observations in this cluster. The issue is that when AI systems compare multiple pharmacies, Amazon Pharmacy is more frequently selected as the top recommendation. Strengthening the citation sources that support comparison-stage prompts, particularly around logistics, delivery speed, and medication availability, is the most direct path to improving the brand's rank position in evaluation-stage responses.

Prompt Evidence

ChatGPT / Best Online Pharmacy Discovery and Evaluation Prompt: "What is the best online pharmacy for affordable prescriptions?" Result: Cost Plus Drugs was recommended in the top two positions, with its transparent pricing model cited as the primary advantage.

Gemini / Online Pharmacy Pricing and Cost Evaluation Prompt: "Which online pharmacy has the lowest prices on generic medications?" Result: Cost Plus Drugs was the first recommendation, with specific pricing examples cited from its public pricing page.

Perplexity / Online Pharmacy Comparison and Alternatives Prompt: "Compare Cost Plus Drugs and Amazon Pharmacy for prescription delivery." Result: Cost Plus Drugs was mentioned but not recommended in the top three positions; Amazon Pharmacy was ranked first, with Prime shipping cited as the deciding factor.

Google AI Mode / Online Pharmacy Comparison and Alternatives Prompt: "What are the best alternatives to CVS Pharmacy for mail-order prescriptions?" Result: Cost Plus Drugs appeared in the response but was listed third behind Amazon Pharmacy and GoodRx, with no specific pricing or service comparison provided.

What CiteWorks Studio Would Do Next

Phase 1: AI Market Discovery Audit Map the full prompt landscape across all six platforms to identify every prompt where Cost Plus Drugs is mentioned, recommended, or displaced by a competitor.

Phase 2: Recommendation Readiness Plan Analyze the citation sources driving Amazon Pharmacy's advantage in comparison-stage prompts and identify the specific evidence gaps preventing Cost Plus Drugs from ranking higher in evaluation responses.

Phase 3: Owned Answer Layer Buildout Develop structured pricing comparison pages, service comparison content, and FAQ content that AI systems can retrieve and cite directly in comparison and evaluation prompts.

Phase 4: Citation and Authority Layer Development Strengthen the public evidence layer on platforms where Cost Plus Drugs underperforms, particularly Perplexity, through citable third-party sources, editorial reviews, and comparison articles.

Phase 5: Monthly AI Visibility and Recommendation Tracking Monitor changes in recommendation coverage, rank position, and sentiment across all platforms and clusters to measure the impact of citation and content improvements over time.

Why This Matters

AI-generated shortlists are becoming the first filter buyers encounter when choosing an online pharmacy. Cost Plus Drugs has built strong recommendation quality and pricing authority, but the gap in comparison-stage prompts means that when buyers evaluate multiple options, Amazon Pharmacy is more frequently the top recommendation. In a market where the top two brands capture a disproportionate share of total opportunity value, improving rank position in evaluation-stage responses is the difference between being a strong challenger and being the default recommendation.

Presence alone is not enough. Cost Plus Drugs is already visible. The next move is targeted correction of the prompt, page, and citation layers that determine whether the brand is listed or recommended when buyers are making their final choice.

Core Metrics

• Mentions: 365
• Valid recommendations: 226
• Top 3 recommendation count: 175
• Rank 1 recommendation count: 80
• Average recommended rank: 2.16
• Positive mentions: 251
• Neutral mentions: 112
• Negative mentions: 2
• Raw mention presence rate: 25.5%
• Valid recommendation coverage: 15.8%
• Top 3 recommendation rate: 12.2%
• Rank 1 recommendation rate: 5.6%
• Strongest cluster by recommendation behavior: Best Online Pharmacy Discovery and Evaluation
• Strongest platform by recommendation behavior: Google AI Mode

Sentiment Score

Sentiment Score = (positive mentions x 1 + neutral mentions x 0 + negative mentions x -1) / total mentions

Cost Plus Drugs: (251 x 1 + 112 x 0 + 2 x -1) / 365 = 249 / 365 = 0.68

This score matters because unclassified mention counts are misleading. A brand with high mention volume but predominantly neutral or cautionary framing is not winning recommendation placement. Cost Plus Drugs achieves the highest net sentiment in the category, meaning its mentions are overwhelmingly positive and recommendation-oriented rather than incidental or comparative.

Share of voice is a diagnostic metric, not a business KPI. A positive recommendation, neutral reference, cautionary mention, and competitor-displaced mention are not equal in commercial terms. Counting all mentions as equivalent wins is bad measurement. Classified sentiment is required before interpreting AI visibility in any meaningful way.

Sentiment by Platform

Methodology

1. Market studied: Online pharmacies, including digital-native services, retail pharmacy chains, PBM-affiliated services, and prescription discount platforms.
2. Brands included: Amazon Pharmacy, Capsule, Cost Plus Drugs, CVS Pharmacy, Express Scripts, GoodRx, Honeybee Health, Optum Rx, PillPack, and Walgreens. This universe covers the major categories but is not a full market census.
3. Data collection window: June 2026, snapshot-based collection.
4. AI platforms tested: ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, and Perplexity.
5. Observations analyzed: 1,431 total observations across all platforms and clusters. Unique prompt count was not available in the public version of this dataset.
6. Prompt clusters: Three public high-intent clusters were analyzed: Best Online Pharmacy Discovery and Evaluation (consideration stage), Online Pharmacy Comparison and Alternatives (evaluation stage), and Online Pharmacy Pricing and Cost Evaluation (decision stage).
7. Definition of a mention: A mention is recorded when the company appeared in an AI-generated response, regardless of sentiment, ranking, or context.
8. Definition of a valid recommendation: A valid recommendation is a positive, shortlist-quality recommendation that earns recommendation credit. Neutral references, cautionary mentions, and comparison-anchor appearances are not counted as valid recommendations.
9. Metrics used: Valid recommendation coverage, top-three rate, rank-one rate, average recommended rank, net sentiment score, monthly AI authority value, and captured share of AI opportunity.
10. Modeled values: Monthly AI authority value figures are modeled benchmark estimates based on commercial intent proxies. They are not revenue, pipeline, or booked demand figures.
11. Limitations: This is a point-in-time benchmark. AI outputs change with model updates, data source changes, and prompt variations. This report reflects publicly available benchmark evidence and is not a full audit or complete market census.

See How AI Is Recommending Your Brand

The benchmark shows where Cost Plus Drugs and its competitors stand in June 2026, but every brand's recommendation profile is different across platforms and prompt types. CiteWorks Studio maps where your brand appears, where competitors are recommended instead, which prompts carry the most commercial risk, which sources are shaping AI answers, and what needs to change to improve recommendation-stage visibility across the platforms where buyers are forming decisions.